Consolidated Planning Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Consolidated Planning Corp's ABBV Position: Q3 2026 in Review
Consolidated Planning Corp increased its AbbVie (ABBV) stake by 65% in Q3 2026, buying an estimated $285K and bringing the position to 2,814 shares worth $736K. The position accounts for 0.1% of the portfolio, ranked #95.
Consolidated Planning Corp first reported a position in ABBV in Q3 2021 and has held it in 15 quarters since. The position peaked at $850K in Q2 2023. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Consolidated Planning Corp held 2,814 shares of AbbVie worth $736K as of Q3 2026.
- Consolidated Planning Corp bought 1,110 AbbVie shares in Q3 2026, an estimated $285K.
- AbbVie made up 0.1% of Consolidated Planning Corp's portfolio in Q3 2026, its #95 holding.
- Consolidated Planning Corp first reported a position in AbbVie in Q3 2021 and has held it in 15 quarters since.
- Consolidated Planning Corp's AbbVie position peaked at $850K in Q2 2023.
- 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Consolidated Planning Corp's 13F filing for Q3 2026, filed 21 Oct 2026.